Dr. Fatima Zaid Abu Zanat is a pioneering leader in pharmaceutical and healthcare industries, with over 17 years of experience ensuring timely patient access to innovative therapies in some of the world’s most dynamic emerging markets. As Regional Director of Regulatory Affairs & Scientific Office at Ipsen Pharma, she blends scientific rigor with strategic leadership, while passionately championing the evolution of regulatory affairs professional into a creative, purpose-driven business partner within Ipsen, partners and beyond.

A pharmacist by training and R&D scientist by education, Dr. Abu Zanat holds three international research publications, two of which are based on her groundbreaking MSc Pharmaceutical Technology thesis on a novel co-drug for dyslipidemia. She also holds the prestigious RAPS Dual Regulatory Affairs Diploma and Certificate. Her contributions to the broader industry include active roles with associations such as RAPS, PhRMA MEA and formerly Mecomed. Her voice and vision continue to be sought after at major, regulatory forums, where she regularly contributes as a speaker and panel moderator.

Her exceptional contributions have earned her prestigious accolades, including the most recent Award of 2025 Global Women Power Leaders for the category of Regulatory Excellence Across Borders, 2023 GCC Regulatory Affairs “Women of the Middle East” Award, 2022 nomination among Ipsen’s top Women of the Year and DUPHAT 2012 3rd Best Professional Poster Award. As a mentor and recognized leader, Dr. Abu Zanat continues to shape the future of regulatory affairs – empowering the next generation to lead with purpose, innovation and integrity.